Lysis of myotubes by alloreactive cytotoxic T cells and natural killer cells. Relevance to myoblast transplantation

R. Hohlfeld, Andrew G Engel

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The aim of this study was to investigate the susceptibility of human myotubes to lysis by the two major types of cytotoxic effector cells, CD3+CD8+ cytotoxic T cells (CTL) and CD16+CD56+ natural killer (NK) cells. The myoblast preparations used as target cells were > 90% pure as assessed by immunostaining with the Leu19 monoclonal antibody (MAb) that cross-reacts with the neural cell adhesion molecule N-CAM. Allospecific CTL lines were generated from mixed lymphocyte cultures, and freshly isolated allogeneic and autologous peripheral blood cells were used as a source of NK cells. The cytotoxicity was observed under phase optics and by immunoelectron microscopy, and was quantitated with a chromium release assay. Myotubes were efficiently killed by allospecific CTL and by autologous and allogeneic NK cells. The killing by CTL was inhibited with an anti-class I HLA MAb, and the killing by NK cells was inhibited by depleting peripheral blood cells of CD16+ cells with anti-CD16 MAb and complement. The results have important implications for myoblast transplantation, an experimental therapy of muscular dystrophy.

Original languageEnglish (US)
Pages (from-to)370-374
Number of pages5
JournalJournal of Clinical Investigation
Volume86
Issue number1
StatePublished - 1990

Fingerprint

Myoblasts
Skeletal Muscle Fibers
Natural Killer Cells
Transplantation
T-Lymphocytes
Monoclonal Antibodies
Blood Cells
Neural Cell Adhesion Molecules
Investigational Therapies
Immunoelectron Microscopy
Muscular Dystrophies
Chromium
Lymphocytes
Cell Line

Keywords

  • allograft rejection
  • cell-mediated cytotoxicity
  • major histocompatibility complex
  • muscular dystrophy
  • neural cell adhesion molecule (N-CAM)

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{e8a73128ebd54eadacdeb1c4d8c18526,
title = "Lysis of myotubes by alloreactive cytotoxic T cells and natural killer cells. Relevance to myoblast transplantation",
abstract = "The aim of this study was to investigate the susceptibility of human myotubes to lysis by the two major types of cytotoxic effector cells, CD3+CD8+ cytotoxic T cells (CTL) and CD16+CD56+ natural killer (NK) cells. The myoblast preparations used as target cells were > 90{\%} pure as assessed by immunostaining with the Leu19 monoclonal antibody (MAb) that cross-reacts with the neural cell adhesion molecule N-CAM. Allospecific CTL lines were generated from mixed lymphocyte cultures, and freshly isolated allogeneic and autologous peripheral blood cells were used as a source of NK cells. The cytotoxicity was observed under phase optics and by immunoelectron microscopy, and was quantitated with a chromium release assay. Myotubes were efficiently killed by allospecific CTL and by autologous and allogeneic NK cells. The killing by CTL was inhibited with an anti-class I HLA MAb, and the killing by NK cells was inhibited by depleting peripheral blood cells of CD16+ cells with anti-CD16 MAb and complement. The results have important implications for myoblast transplantation, an experimental therapy of muscular dystrophy.",
keywords = "allograft rejection, cell-mediated cytotoxicity, major histocompatibility complex, muscular dystrophy, neural cell adhesion molecule (N-CAM)",
author = "R. Hohlfeld and Engel, {Andrew G}",
year = "1990",
language = "English (US)",
volume = "86",
pages = "370--374",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "1",

}

TY - JOUR

T1 - Lysis of myotubes by alloreactive cytotoxic T cells and natural killer cells. Relevance to myoblast transplantation

AU - Hohlfeld, R.

AU - Engel, Andrew G

PY - 1990

Y1 - 1990

N2 - The aim of this study was to investigate the susceptibility of human myotubes to lysis by the two major types of cytotoxic effector cells, CD3+CD8+ cytotoxic T cells (CTL) and CD16+CD56+ natural killer (NK) cells. The myoblast preparations used as target cells were > 90% pure as assessed by immunostaining with the Leu19 monoclonal antibody (MAb) that cross-reacts with the neural cell adhesion molecule N-CAM. Allospecific CTL lines were generated from mixed lymphocyte cultures, and freshly isolated allogeneic and autologous peripheral blood cells were used as a source of NK cells. The cytotoxicity was observed under phase optics and by immunoelectron microscopy, and was quantitated with a chromium release assay. Myotubes were efficiently killed by allospecific CTL and by autologous and allogeneic NK cells. The killing by CTL was inhibited with an anti-class I HLA MAb, and the killing by NK cells was inhibited by depleting peripheral blood cells of CD16+ cells with anti-CD16 MAb and complement. The results have important implications for myoblast transplantation, an experimental therapy of muscular dystrophy.

AB - The aim of this study was to investigate the susceptibility of human myotubes to lysis by the two major types of cytotoxic effector cells, CD3+CD8+ cytotoxic T cells (CTL) and CD16+CD56+ natural killer (NK) cells. The myoblast preparations used as target cells were > 90% pure as assessed by immunostaining with the Leu19 monoclonal antibody (MAb) that cross-reacts with the neural cell adhesion molecule N-CAM. Allospecific CTL lines were generated from mixed lymphocyte cultures, and freshly isolated allogeneic and autologous peripheral blood cells were used as a source of NK cells. The cytotoxicity was observed under phase optics and by immunoelectron microscopy, and was quantitated with a chromium release assay. Myotubes were efficiently killed by allospecific CTL and by autologous and allogeneic NK cells. The killing by CTL was inhibited with an anti-class I HLA MAb, and the killing by NK cells was inhibited by depleting peripheral blood cells of CD16+ cells with anti-CD16 MAb and complement. The results have important implications for myoblast transplantation, an experimental therapy of muscular dystrophy.

KW - allograft rejection

KW - cell-mediated cytotoxicity

KW - major histocompatibility complex

KW - muscular dystrophy

KW - neural cell adhesion molecule (N-CAM)

UR - http://www.scopus.com/inward/record.url?scp=0025362266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025362266&partnerID=8YFLogxK

M3 - Article

C2 - 2365826

AN - SCOPUS:0025362266

VL - 86

SP - 370

EP - 374

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 1

ER -